4.7 Article

Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Dermatology

Nutrition and melanoma prevention

Madeline E. DeWane et al.

Summary: Considerable research has been conducted in recent years on the impact of dietary factors and nutritional elements on melanoma risk. Various dietary compounds have been studied, but only a selected group is discussed in this review. Many compounds show promising evidence in vitro, and some have been associated with reduced melanoma risk in epidemiologic studies, although data from randomized controlled trials in humans are lacking. Future studies may provide further insights into the potential role of dietary components in reducing melanoma risk.

CLINICS IN DERMATOLOGY (2022)

Review Biotechnology & Applied Microbiology

Immune checkpoint inhibitors for the treatment of melanoma

Francesco Sabbatino et al.

Summary: Immune checkpoint inhibitors (ICIs) are an important part of melanoma treatment, but their efficacy is limited by immune escape mechanisms. Therefore, further studies are needed to confirm the effectiveness of combining different classes of ICIs and combining ICIs with other types of therapies. In addition, new and more effective predictive biomarkers are needed to more accurately define the therapeutic algorithms for melanoma patients.

EXPERT OPINION ON BIOLOGICAL THERAPY (2022)

Article Biochemistry & Molecular Biology

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

Alexander X. Lozano et al.

Summary: This study provides new insights into the immunological state prior to the development of immune-related adverse events (irAEs) in patients with melanoma treated with immune checkpoint inhibitors (ICIs). The abundance of activated CD4 memory T cells and T cell receptor diversity in the blood samples were found to be associated with severe irAEs, regardless of the affected organ system. The study also investigated the changes in T cell receptor clonality during combination therapy and linked them to the severity and timing of irAE onset. These findings have implications for improved diagnostics and clinical management of irAEs.

NATURE MEDICINE (2022)

Article Oncology

Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies

Hanxin Liu et al.

Summary: The tumor microenvironment plays a major role in the malignancy and therapeutic resistance of cancer, with intercellular communication contributing to this process. Immune evasion, extracellular matrix remodeling, and therapy-induced senescence (TIS) all contribute to cancer resistance and disease progression. The senescence-associated secretory phenotype (SASP) of senescent cells drives inflammation and promotes tumor relapse and distant metastasis. selectively removing senescent cells may be a promising strategy to prevent drug resistance associated with the remodelled tumor microenvironment.

SEMINARS IN CANCER BIOLOGY (2022)

Article Oncology

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity

Hanfeng Wang et al.

Summary: Recent studies have found that CMTM6 promotes tumor progression and modulates tumor immunity in clear cell renal cell carcinoma (ccRCC) by regulating programmed death-ligand 1 stability. Depletion of CMTM6 impairs the proliferation, migration, and invasion of ccRCC cells and promotes anti-tumor immunity. Loss of CMTM6 activates DNA damage response, leading to cellular senescence and upregulation of inflammatory factors.

ONCOIMMUNOLOGY (2022)

Article Dermatology

Melanoma: An update on systemic therapies

Lauren Skudalski et al.

Summary: This article provides dermatologists with an up-to-date working knowledge of the treatment options prescribed by oncologists for patients with unresectable stage III, stage IV, and recurrent melanoma, who often cannot undergo surgical clearance due to the nature of their disease.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Dermatology

Melanoma: How and when to consider clinical diagnostic technologies

Lauren Skudalski et al.

Summary: This article presents practical advice on how and when to incorporate various noninvasive melanoma detection techniques into clinical practice, in response to the increasing rates of melanoma worldwide. The aim is to facilitate early detection of melanoma and reduce unnecessary biopsies of benign pigmented lesions.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Review Cell Biology

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma

Ahmad Najem et al.

Summary: This review provides a detailed overview of phenotype switching in melanoma, including the key regulatory factors, epigenetic modifications, metabolic rewiring, and the role of the tumor microenvironment and oxidative stress. The review also discusses rational therapeutic approaches to improve treatment response in melanoma patients.

CELLS (2022)

Article Cell Biology

IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma

Lorenzo Homann et al.

Summary: Immune checkpoint blockade therapy is an effective treatment for melanoma, and its mechanisms of action involve the activation of CD4(+) and CD8(+) T cells. This study compared the senescence-associated secretory phenotype (SASP) of cytokine-induced senescent cells with therapy-induced senescent cells, and found that the SASP factors were more pronounced in cytokine-induced senescent cells. Furthermore, the conditioned media derived from cytokine and certain drug-treated cells were able to induce senescence characteristics in melanoma cells.

CELLS (2022)

Article Biochemistry & Molecular Biology

Redox-Related Proteins in Melanoma Progression

Larissa A. C. Carvalho et al.

Summary: Melanoma, the most aggressive type of skin cancer, is influenced by redox imbalance and redox proteins may serve as biomarkers and potential targets. Understanding genetic alterations and protein expression in melanoma patients can provide clues for new therapies.

ANTIOXIDANTS (2022)

Review Oncology

Cellular senescence and the tumour microenvironment

Masaki Takasugi et al.

Summary: The senescence-associated secretory phenotype (SASP) produced by senescent cells can remodel the tumor microenvironment and have both suppressive and promoting effects on tumor development, depending on cell type and context-dependency.

MOLECULAR ONCOLOGY (2022)

Article Multidisciplinary Sciences

NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer

Lili Yi et al.

Summary: This study explores the relationship between NTN4 and prognosis as well as immune infiltration in breast cancer using public databases and immunohistochemistry. It found that NTN4 expression is significantly lower in invasive breast carcinoma and low expression is associated with poorer survival. Furthermore, NTN4 is closely related to infiltration levels of specific immune cells and varies among different subtypes of breast cancer.

SCIENTIFIC REPORTS (2022)

Article Pharmacology & Pharmacy

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma

Haozhen Lv et al.

Summary: In this study, the correlation between cuproptosis-related genes and the prognosis of melanoma was explored by accessing and analyzing a public database. LIPT1 was identified as an important gene with prognostic value for melanoma patients. The study also revealed the correlation between LIPT1 expression and immune infiltration in melanoma, providing new clues for the prognostic assessment and immunotherapy of melanoma.

FRONTIERS IN PHARMACOLOGY (2022)

Review Oncology

Senescence and cancer - role and therapeutic opportunities

Clemens A. Schmitt et al.

Summary: This review discusses the mechanisms of senescent cells in both anti-cancer and pro-cancer effects, and describes the potential of various senescence-based therapies in oncology.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Oncology

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy

Xia Liu et al.

Summary: Current study demonstrates that both mouse malignant tumor cells and regulatory T cells can induce T cell senescence, which can be prevented by blocking ATM-associated DNA damage and/or MAPK signaling pathways, resulting in enhanced antitumor immunity. Targeting effector T cell senescence, in combination with anti-PD-L1 checkpoint blockade, proves to be an effective strategy to synergistically enhance cancer immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Review Dermatology

Melanoma surgery-An update

Uwe Wollina

Summary: This narrative review discusses the application of surgery in the diagnosis, treatment of primary tumors, and metastasis of cutaneous melanoma in the era of new and effective medical treatment options. While surgery remains important in the diagnosis and treatment of primary melanoma, therapeutic lymphadenectomy has lost its importance. Sentinel lymph node diagnostics and metastasectomy are useful in a tailored individual approach of combined treatments.

DERMATOLOGIC THERAPY (2022)

Review Oncology

Mechanisms of immune activation and regulation: lessons from melanoma

Shelly Kalaora et al.

Summary: Melanoma, a highly immunogenic skin cancer, involves complex immune responses. This research is crucial for the development of new cancer therapies.

NATURE REVIEWS CANCER (2022)

Review Medicine, Research & Experimental

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

Sreya Bagchi et al.

Summary: This article highlights the significance of immune checkpoint inhibitors in cancer immunotherapy and the research findings on the changes in local and systemic immune cells after treatment. It emphasizes the need for understanding the requirements for an effective and safe antitumor immune response following ICI therapy.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)

Review Biochemistry & Molecular Biology

Bcl-xL as a Modulator of Senescence and Aging

Cristina Mas-Bargues et al.

Summary: Cellular senescence is related to the inability of cells to adapt to stress conditions, a specific level of senescence can promote development, remodeling and healing, while chronicity of senescence can result from constant stresses and a weakening immune system. Centenarians overexpress Bcl-xL, which helps them avoid the deleterious effects of accumulated senescent cells and maintain a fully functional immune system. There is a paradox in the fact that Bcl-xL inhibitors have been shown to protect from aging in animal models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Plant Sciences

Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1 alpha pathway

Jingfeng Liu et al.

Summary: In this study, we demonstrated that DMB inhibits NSCLC progression by inducing cell cycle arrest and triggering cellular senescence through downregulating the c-Myc/HIF-1 alpha pathway. We also found that DMB suppresses cell migration by inhibiting epithelial-mesenchymal transition (EMT) and accelerates senescence by suppressing HIF-1 alpha expression in NSCLC cells. Additionally, DMB decreases c-Myc expression, an upstream regulator of HIF-1 alpha.

PHYTOMEDICINE (2021)

Review Immunology

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Karthik Dhatchinamoorthy et al.

Summary: Loss of MHC I antigen presentation is common in many cancers, which may impair immune responses and affect the efficacy of immunotherapy. Studies have discussed underlying mechanisms through which some cancers evade immune killing by shutting down the MHC I pathway, and proposed potential strategies to overcome this limitation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation

Tina Jost et al.

Summary: The CDK4/6 inhibitor palbociclib induces cell cycle arrest in the G0/G1 phase, with minimal impact on cell death. It enhances cellular growth arrest and senescence in cancer cells, and may downregulate FOXM1 to induce senescence. Combination therapy with palbociclib and radiotherapy shows an additive effect on cellular growth arrest and deserves further study in clinical trials.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

Pataje G. Prasanna et al.

Summary: Cellular senescence is crucial in suppressing tumor growth, but radiation and chemotherapy can lead to accumulation of senescent cells in both tumor and normal tissues, potentially promoting tumor relapse and resistance to treatment. Targeting cellular senescence could be important in the fight against cancer.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Review Cell Biology

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

Ruchi Kumari et al.

Summary: Cellular senescence is a stable cell cycle arrest triggered in response to various stimuli, characterized by dynamic changes in senescent cells. It has both positive effects on tissue repair and anti-cancer mechanisms, but can also negatively impact organismal health. Multiple pathways, including p53/p21 and p16/pRB, play central roles in regulating this process.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients

Anne Zaremba et al.

Summary: The review evaluated the latest long-term data from clinical trials for melanoma patients, showing that retreatment, rechallenge, and escalation are viable options for patients who relapse in the adjuvant or advanced setting.

EUROPEAN JOURNAL OF CANCER (2021)

Article Medicine, General & Internal

Immune checkpoint inhibitors in melanoma

Matteo S Carlino et al.

LANCET (2021)

Correction Cell Biology

The Paradoxical Role of Cellular Senescence in Cancer (vol 9, 722205, 2021)

Jing Yang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology

Annelise Vermot et al.

Summary: NADPH oxidase (NOX) enzymes, which produce reactive oxygen species (ROS), play crucial roles in physiological processes such as immune defense, protein post-translational processing, cellular signaling, gene expression regulation, and cell differentiation. However, dysregulation of NOX can lead to various severe pathologies, making them potential therapeutic targets. Understanding the molecular mechanisms behind NOX regulation and ROS production is essential for investigating human diseases and developing new treatments.

ANTIOXIDANTS (2021)

Article Oncology

Quercetin-Mediated Apoptosis and Cellular Senescence in Human Colon Cancer

Serpil Ozsoy et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Cellular and Molecular Mechanisms of CD8(+) T Cell Differentiation, Dysfunction and Exhaustion

Daniel J. Verdon et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

G3BP1 controls the senescence-associated secretome and its impact on cancer progression

Amr Omer et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma

Fabienne Maibach et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Cell Biology

Senescence and the SASP: many therapeutic avenues

Jodie Birch et al.

GENES & DEVELOPMENT (2020)

Review Biochemistry & Molecular Biology

The Influence of Tumor Microenvironment on Immune Escape of Melanoma

Aleksandra Simiczyjew et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Human innate immune cell crosstalk induces melanoma cell senescence

Felix Funck et al.

ONCOIMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Centrosome dysfunction: a link between senescence and tumor immunity

Qi Wu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Physiology

CELLULAR SENESCENCE: AGING, CANCER, AND INJURY

Arianna Calcinotto et al.

PHYSIOLOGICAL REVIEWS (2019)

Article Immunology

Senescent cell clearance by the immune system: Emerging therapeutic opportunities

Larissa G.P. Langhi Prata et al.

SEMINARS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition

Branca I. Pereira et al.

NATURE COMMUNICATIONS (2019)

Review Pathology

The role of oxidative stress in the biology of melanoma: A systematic review

Serafinella Patrizia Cannavo et al.

PATHOLOGY RESEARCH AND PRACTICE (2019)

Review Medicine, General & Internal

Melanoma

Dirk Schadendorf et al.

LANCET (2018)

Article Dermatology

Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence

Jennifer M. Huang et al.

DERMATOLOGIC CLINICS (2017)

Review Oncology

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

Geoffrey T. Gibney et al.

LANCET ONCOLOGY (2016)

Article Biotechnology & Applied Microbiology

Consensus clustering and functional interpretation of gene-expression data

S Swift et al.

GENOME BIOLOGY (2004)